Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

Name: Work Video:
Duration: 3 min 30 s
David Cunningham; Eliza A. Hawkes; Andrew Jack; Wendi Qian; Paul Smith; Paul Mouncey; Christopher Pocock; Kirit M. Ardeshna; John Radford; Andrew McMillan; John Davies; Deborah Turner; Anton Kruger; Peter Johnson; Joanna Gambell; David C. Linch
{'id': 'https://openalex.org/W2171356556', 'doi': 'https://doi.org/10.1016/s0140-6736(13)60313-x', 'title': 'Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles', 'display_name': 'Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles', 'publication_year': 2013, 'publication_date': '2013-04-22', 'ids': {'openalex': 'https://openalex.org/W2171356556', 'doi': 'https://doi.org/10.1016/s0140-6736(13)60313-x', 'mag': '2171356556', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/23615461'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0140-6736(13)60313-x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S49861241', 'display_name': 'The Lancet', 'issn_l': '0140-6736', 'issn': ['0140-6736', '1474-547X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'green', 'oa_url': 'https://figshare.com/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130/1/files/18400577.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056345420', 'display_name': 'David Cunningham', 'orcid': 'https://orcid.org/0000-0001-5158-1069'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': True, 'raw_author_name': 'David Cunningham', 'raw_affiliation_strings': ['Royal Marsden NHS Foundation Trust, London and Surrey, UK'], 'affiliations': [{'raw_affiliation_string': 'Royal Marsden NHS Foundation Trust, London and Surrey, UK', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006324385', 'display_name': 'Eliza A. Hawkes', 'orcid': 'https://orcid.org/0000-0002-0376-2559'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Eliza A Hawkes', 'raw_affiliation_strings': ['Royal Marsden NHS Foundation Trust, London and Surrey, UK'], 'affiliations': [{'raw_affiliation_string': 'Royal Marsden NHS Foundation Trust, London and Surrey, UK', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067838760', 'display_name': 'Andrew Jack', 'orcid': 'https://orcid.org/0000-0001-9620-4734'}, 'institutions': [{'id': 'https://openalex.org/I2801331674', 'display_name': "St James's University Hospital", 'ror': 'https://ror.org/013s89d74', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799390153', 'https://openalex.org/I2801331674']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Andrew Jack', 'raw_affiliation_strings': ["St James' Institute of Oncology, Leeds, UK"], 'affiliations': [{'raw_affiliation_string': "St James' Institute of Oncology, Leeds, UK", 'institution_ids': ['https://openalex.org/I2801331674']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102861214', 'display_name': 'Wendi Qian', 'orcid': 'https://orcid.org/0000-0002-4238-3471'}, 'institutions': [{'id': 'https://openalex.org/I4210091428', 'display_name': 'MRC Clinical Trials Unit at UCL', 'ror': 'https://ror.org/001mm6w73', 'country_code': 'GB', 'type': 'facility', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I4210087105', 'https://openalex.org/I4210091428', 'https://openalex.org/I45129253', 'https://openalex.org/I90344618']}, {'id': 'https://openalex.org/I90344618', 'display_name': 'Medical Research Council', 'ror': 'https://ror.org/03x94j517', 'country_code': 'GB', 'type': 'government', 'lineage': ['https://openalex.org/I4210087105', 'https://openalex.org/I90344618']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Wendi Qian', 'raw_affiliation_strings': ['Cambridge Cancer Trials Centre, Cambridge Clinical Trials Unit–Cancer Theme and Medical Research Council Biostatistics Unit Hub for Trials Methodology, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Cambridge Cancer Trials Centre, Cambridge Clinical Trials Unit–Cancer Theme and Medical Research Council Biostatistics Unit Hub for Trials Methodology, Cambridge, UK', 'institution_ids': ['https://openalex.org/I4210091428', 'https://openalex.org/I90344618']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104353104', 'display_name': 'Paul Smith', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}, {'id': 'https://openalex.org/I45129253', 'display_name': 'University College London', 'ror': 'https://ror.org/02jx3x895', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I45129253']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Paul Smith', 'raw_affiliation_strings': ['Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK', 'institution_ids': ['https://openalex.org/I2801316944', 'https://openalex.org/I45129253']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059004773', 'display_name': 'Paul Mouncey', 'orcid': 'https://orcid.org/0000-0002-8510-8517'}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}, {'id': 'https://openalex.org/I45129253', 'display_name': 'University College London', 'ror': 'https://ror.org/02jx3x895', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I45129253']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Paul Mouncey', 'raw_affiliation_strings': ['Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK', 'institution_ids': ['https://openalex.org/I2801316944', 'https://openalex.org/I45129253']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033024327', 'display_name': 'Christopher Pocock', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802726858', 'display_name': 'East Kent Hospitals University NHS Foundation Trust', 'ror': 'https://ror.org/02dqqj223', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802726858']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Christopher Pocock', 'raw_affiliation_strings': ['East Kent Hospitals, Canterbury, UK'], 'affiliations': [{'raw_affiliation_string': 'East Kent Hospitals, Canterbury, UK', 'institution_ids': ['https://openalex.org/I2802726858']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053161231', 'display_name': 'Kirit M. Ardeshna', 'orcid': 'https://orcid.org/0000-0002-8938-7875'}, 'institutions': [{'id': 'https://openalex.org/I4210108939', 'display_name': 'Mount Vernon Cancer Centre', 'ror': 'https://ror.org/01wwv4x50', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210108939', 'https://openalex.org/I4210122718']}, {'id': 'https://openalex.org/I45129253', 'display_name': 'University College London', 'ror': 'https://ror.org/02jx3x895', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I45129253']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kirit M Ardeshna', 'raw_affiliation_strings': ['Mount Vernon Cancer Centre, Northwood, UK', 'University College London, UK'], 'affiliations': [{'raw_affiliation_string': 'Mount Vernon Cancer Centre, Northwood, UK', 'institution_ids': ['https://openalex.org/I4210108939']}, {'raw_affiliation_string': 'University College London, UK', 'institution_ids': ['https://openalex.org/I45129253']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011398209', 'display_name': 'John Radford', 'orcid': 'https://orcid.org/0000-0001-7898-2786'}, 'institutions': [{'id': 'https://openalex.org/I4210133995', 'display_name': 'The Christie NHS Foundation Trust', 'ror': 'https://ror.org/03v9efr22', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210133995']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John A Radford', 'raw_affiliation_strings': ['University of Manchester and the Christie NHS Foundation Trust, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'University of Manchester and the Christie NHS Foundation Trust, Manchester, UK', 'institution_ids': ['https://openalex.org/I4210133995', 'https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022624109', 'display_name': 'Andrew McMillan', 'orcid': 'https://orcid.org/0000-0002-8737-8465'}, 'institutions': [{'id': 'https://openalex.org/I2802921333', 'display_name': 'Nottingham City Hospital', 'ror': 'https://ror.org/0022b3c04', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334287468', 'https://openalex.org/I2802921333']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Andrew McMillan', 'raw_affiliation_strings': ['Nottingham City Hospital, Nottingham, UK'], 'affiliations': [{'raw_affiliation_string': 'Nottingham City Hospital, Nottingham, UK', 'institution_ids': ['https://openalex.org/I2802921333']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109385278', 'display_name': 'John Davies', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800150677', 'display_name': 'Western General Hospital', 'ror': 'https://ror.org/009kr6r15', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1324252669', 'https://openalex.org/I2800150677']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John Davies', 'raw_affiliation_strings': ['Western General Hospital, Edinburgh, UK'], 'affiliations': [{'raw_affiliation_string': 'Western General Hospital, Edinburgh, UK', 'institution_ids': ['https://openalex.org/I2800150677']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009133053', 'display_name': 'Deborah Turner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801905823', 'display_name': 'Torbay Hospital', 'ror': 'https://ror.org/01vv3y523', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801905823', 'https://openalex.org/I4210153833']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Deborah Turner', 'raw_affiliation_strings': ['Torbay Hospital, Torquay, UK'], 'affiliations': [{'raw_affiliation_string': 'Torbay Hospital, Torquay, UK', 'institution_ids': ['https://openalex.org/I2801905823']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110196410', 'display_name': 'Anton Kruger', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2799759729', 'display_name': 'Royal Cornwall Hospital', 'ror': 'https://ror.org/00cfdk448', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799477489', 'https://openalex.org/I2799759729']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Anton Kruger', 'raw_affiliation_strings': ['Royal Cornwall Hospital, Truro, UK'], 'affiliations': [{'raw_affiliation_string': 'Royal Cornwall Hospital, Truro, UK', 'institution_ids': ['https://openalex.org/I2799759729']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007119947', 'display_name': 'Peter Johnson', 'orcid': 'https://orcid.org/0000-0003-2306-4974'}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Peter Johnson', 'raw_affiliation_strings': ['Cancer Research UK Centre, Southampton, UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK Centre, Southampton, UK', 'institution_ids': ['https://openalex.org/I2801316944']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110433958', 'display_name': 'Joanna Gambell', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2801316944', 'display_name': 'Cancer Research UK', 'ror': 'https://ror.org/054225q67', 'country_code': 'GB', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I2801316944']}, {'id': 'https://openalex.org/I45129253', 'display_name': 'University College London', 'ror': 'https://ror.org/02jx3x895', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I45129253']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Joanna Gambell', 'raw_affiliation_strings': ['Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK'], 'affiliations': [{'raw_affiliation_string': 'Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London UK', 'institution_ids': ['https://openalex.org/I2801316944', 'https://openalex.org/I45129253']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5005708709', 'display_name': 'David C. Linch', 'orcid': 'https://orcid.org/0000-0002-9988-5528'}, 'institutions': [{'id': 'https://openalex.org/I45129253', 'display_name': 'University College London', 'ror': 'https://ror.org/02jx3x895', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I45129253']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'David Linch', 'raw_affiliation_strings': ['University College London, UK'], 'affiliations': [{'raw_affiliation_string': 'University College London, UK', 'institution_ids': ['https://openalex.org/I45129253']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 14, 'corresponding_author_ids': ['https://openalex.org/A5056345420'], 'corresponding_institution_ids': ['https://openalex.org/I1325846038'], 'apc_list': {'value': 6830, 'currency': 'USD', 'value_usd': 6830, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 35.208, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 512, 'citation_normalized_percentile': {'value': 0.999927, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '381', 'issue': '9880', 'first_page': '1817', 'last_page': '1826'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9964, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10685', 'display_name': 'Viral-associated cancers and disorders', 'score': 0.9949, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/prednisolone', 'display_name': 'Prednisolone', 'score': 0.7797344}], 'concepts': [{'id': 'https://openalex.org/C2779429289', 'wikidata': 'https://www.wikidata.org/wiki/Q408977', 'display_name': 'Vincristine', 'level': 4, 'score': 0.9043084}, {'id': 'https://openalex.org/C2779725641', 'wikidata': 'https://www.wikidata.org/wiki/Q1076228', 'display_name': 'CHOP', 'level': 3, 'score': 0.85150254}, {'id': 'https://openalex.org/C2780653079', 'wikidata': 'https://www.wikidata.org/wiki/Q412323', 'display_name': 'Rituximab', 'level': 3, 'score': 0.8394351}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8024243}, {'id': 'https://openalex.org/C2776715498', 'wikidata': 'https://www.wikidata.org/wiki/Q11426176', 'display_name': 'Prednisolone', 'level': 2, 'score': 0.7797344}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.68005204}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.6215346}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.53840756}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5376443}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.41290972}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.32272002}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D016403', 'descriptor_name': 'Lymphoma, Large B-Cell, Diffuse', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058846', 'descriptor_name': 'Antibodies, Monoclonal, Murine-Derived', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D058846', 'descriptor_name': 'Antibodies, Monoclonal, Murine-Derived', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016403', 'descriptor_name': 'Lymphoma, Large B-Cell, Diffuse', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011241', 'descriptor_name': 'Prednisone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011241', 'descriptor_name': 'Prednisone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069283', 'descriptor_name': 'Rituximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/s0140-6736(13)60313-x', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S49861241', 'display_name': 'The Lancet', 'issn_l': '0140-6736', 'issn': ['0140-6736', '1474-547X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': True, 'landing_page_url': 'https://figshare.com/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130', 'pdf_url': 'https://figshare.com/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130/1/files/18400577.pdf', 'source': {'id': 'https://openalex.org/S4306400572', 'display_name': 'OPAL (Open@LaTrobe) (La Trobe University)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I196829312', 'host_organization_name': 'La Trobe University', 'host_organization_lineage': ['https://openalex.org/I196829312'], 'host_organization_lineage_names': ['La Trobe University'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://hdl.handle.net/2381/39301', 'pdf_url': 'https://figshare.le.ac.uk/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130/1/files/18400577.pdf', 'source': {'id': 'https://openalex.org/S4306402365', 'display_name': 'Leicester Research Archive (University of Leicester)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I153648349', 'host_organization_name': 'University of Leicester', 'host_organization_lineage': ['https://openalex.org/I153648349'], 'host_organization_lineage_names': ['University of Leicester'], 'type': 'repository'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/23615461', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://figshare.com/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130', 'pdf_url': 'https://figshare.com/articles/journal_contribution/Rituximab_plus_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_in_patients_with_newly_diagnosed_diffuse_large_B-cell_non-Hodgkin_lymphoma_a_phase_3_comparison_of_dose_intensification_with_14-day_versus_21-day_cycles/10207130/1/files/18400577.pdf', 'source': {'id': 'https://openalex.org/S4306400572', 'display_name': 'OPAL (Open@LaTrobe) (La Trobe University)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I196829312', 'host_organization_name': 'La Trobe University', 'host_organization_lineage': ['https://openalex.org/I196829312'], 'host_organization_lineage_names': ['La Trobe University'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.73, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 38, 'referenced_works': ['https://openalex.org/W1912693401', 'https://openalex.org/W1978932947', 'https://openalex.org/W2008016070', 'https://openalex.org/W2018071905', 'https://openalex.org/W2037796411', 'https://openalex.org/W2042137630', 'https://openalex.org/W2057239580', 'https://openalex.org/W2058015212', 'https://openalex.org/W2065157786', 'https://openalex.org/W2078719089', 'https://openalex.org/W2106928992', 'https://openalex.org/W2108465006', 'https://openalex.org/W2111716055', 'https://openalex.org/W2117754708', 'https://openalex.org/W2118935462', 'https://openalex.org/W2120415962', 'https://openalex.org/W2126779872', 'https://openalex.org/W2133505776', 'https://openalex.org/W2133869962', 'https://openalex.org/W2137216850', 'https://openalex.org/W2139741970', 'https://openalex.org/W2139942643', 'https://openalex.org/W2142814377', 'https://openalex.org/W2147246240', 'https://openalex.org/W2153665789', 'https://openalex.org/W2153944703', 'https://openalex.org/W2158267770', 'https://openalex.org/W2159285007', 'https://openalex.org/W2160305510', 'https://openalex.org/W2162693374', 'https://openalex.org/W2166157350', 'https://openalex.org/W2261221338', 'https://openalex.org/W2309349001', 'https://openalex.org/W2318772898', 'https://openalex.org/W2564026979', 'https://openalex.org/W2599623573', 'https://openalex.org/W417406195', 'https://openalex.org/W4783994'], 'related_works': ['https://openalex.org/W2464279489', 'https://openalex.org/W2418155614', 'https://openalex.org/W2360588610', 'https://openalex.org/W2330662417', 'https://openalex.org/W2145349532', 'https://openalex.org/W2083438316', 'https://openalex.org/W2075288748', 'https://openalex.org/W2050519214', 'https://openalex.org/W2049131728', 'https://openalex.org/W1937017173'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2171356556', 'counts_by_year': [{'year': 2024, 'cited_by_count': 33}, {'year': 2023, 'cited_by_count': 30}, {'year': 2022, 'cited_by_count': 41}, {'year': 2021, 'cited_by_count': 57}, {'year': 2020, 'cited_by_count': 50}, {'year': 2019, 'cited_by_count': 46}, {'year': 2018, 'cited_by_count': 47}, {'year': 2017, 'cited_by_count': 43}, {'year': 2016, 'cited_by_count': 44}, {'year': 2015, 'cited_by_count': 66}, {'year': 2014, 'cited_by_count': 35}, {'year': 2013, 'cited_by_count': 15}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-20T01:07:28.435034', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
